Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Apr 19, 2025; 15(4): 102852
Published online Apr 19, 2025. doi: 10.5498/wjp.v15.i4.102852
Optimizing chemotherapy outcomes: The role of mindfulness in Epirubicin treatment for urinary tumors
Pouria Abolfazli, Cristina Nkene Apue Nchama, Brandon Lucke-Wold
Pouria Abolfazli, Cristina Nkene Apue Nchama, Health Science Center, Xi'an Jiaotong University, Xi’an 710061, Shaanxi Province, China
Brandon Lucke-Wold, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32608, United States
Author contributions: Abolfazli P and Lucke-Wold B designed the overall concept and outline of the manuscript; Apue Nchama CN contributed to the discussion and design of the manuscript; Abolfazli P, Apue Nchama CN, and Lucke-Wold B contributed to this paper, the writing, and editing the manuscript and review of literature; all of the authors read and approved the final version of the manuscript to be published.
Conflict-of-interest statement: Abolfazli P, Apue Nchama CN, and Lucke-Wold B have nothing to disclose.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Brandon Lucke-Wold, MD, PhD, Lillian S. Wells Department of Neurosurgery, University of Florida, 1505 SW Archer Road, Gainesville, FL 32608, United States. brandon.lucke-wold@neurosurgery.ufl.edu
Received: October 31, 2024
Revised: January 21, 2025
Accepted: February 5, 2025
Published online: April 19, 2025
Processing time: 145 Days and 21.4 Hours
Core Tip

Core Tip: Urinary system tumors often cause varying degrees of negative psychological symptoms, such as depression and dysphoria. These psychological factors significantly impact patients’ immune function and indirectly affect the intervention and prognosis of patients with cancer. Epirubicin (EPI) can improve the prognosis of patients with urinary system tumors, but it also has certain side effects. Mindfulness interventions are beneficial for enhancing psychological adaptability in cancer patients. In this study, the combination of EPI and mindfulness intervention achieved remarkable clinical results in patients with depression-complicated urinary system tumors.